Inositol waxay muujinaysaa balanqaad sida daaweyn asaasi ah oo loogu talagalay haweenka qaba PCOS sababtoo ah awooda ay u leedahay hagaajinta dheef-shiid kiimikaadka iyo taranka. Waa kuwee waxa la ogaanayo.
Inositols waa Rasuullo Sare
Inositols sida myo iyo d-chiro inositol (DCI), ayaa xubno ka ah fitamiinada B-vitamin iyo qayb ka mid ah xuubka unugyada. Inositol waxaa laga helaa cuntooyinka sida miraha , digirta, miro, iyo lowska oo sidoo kale waxaa sameeya jirka.
Myo iyo DCI waxay u shaqeeyaan malaa'igaha labaad iyagoo raacaya calaamado ku lug leh qawaaniinta insulin. Waxaa la rumeysan yahay in haweenka haysta PCOS ay leeyihiin cillad ku jirta awoodda jirka ee loogu bedelayo MYO-ga DCI, oo wax ka geysta caabbinta insulin iyo dhalmo la'aan. Kala-saarida inositol waa loo dulqaadan yahay (wax saameyn ah GI-ga sida metformin) waxaana lagu muujiyay in la hagaajiyo heerarka insulin oo la yareeyo jahwareer aad u daran.
Ugu Fiican Iskudhufitka Myo iyo D-Chiro
Cilmi-baaris cusub oo lagu sameeyo saameynta unugyada ayaa waxay muujisay in inta badan unugyada jidhka ku jira ay leeyihiin saamiga myo ee DCI ee 40: 1. Qaadashada isku dhafka labadan siyaabood ee sicirkaan halkii aad ka qaadan lahayd myo ama DCI oo kaliya, ayaa lagula talinayaa.
Marka la barbar dhigo myoositol, isku-darka myo ah ee DCI wuxuu muujiyay faa'iidooyin badan oo lagu hagaajinayo xuduudaha dheef-shiid kiimikaad (hoos u dhigista insulin, cholesterol, iyo calaamadaha bararka ) ee haweenka qaba PCOS.
Marka la barbardhigo metformin , isku-darka miyirka iyo DCI ee isku-dhafka 40: 1 ayaa muujiyey natiijooyin aad u wanaagsan oo ku saabsan miisaanka lumay, uureysiga, iyo uurarka (46.7 vs.11.2%).
Ratio inositol wuxuu saameeyaa Tayada Hilibka iyo Dheecaanka
Is barbardhiga saamiga jidhka ee jirka ee miisaanka u dhaxeeya DCI waxay saameyn kartaa tayada ukunta. Myo inositol ayaa lagu muujiyay in ay kor u qaadeyso tayada ukunta ee haweenka leh PCOS halka DCI ay maamusho qiyaaso badan (600-2400 mg maalintii) ayaa lagu ogaaday inay si xun u saameynayaan tayada oocyte iyo jawaabta ugxan-la'aanta.
Maxaase ka sii badan, qadarka sare ee DCI (iyo isku dheelitir la'aanta saamiga MYO-ga ee DCI), ayaa sii xumaatay tayada oocyte iyo jawaabta ugxan-la'aanta.
Inositol waxay yareyn kartaa halista cudurka macaanka ee uurka
Waxaa la soo jeediyay in haweenka haysta PCOS ay halis dheeraad ah u tahay inay uur-qaadaan (GDM) ee uurka. Daraasaduhu waxay muujiyeen in dhamaystirka maaddada myos ee uurka oo dhan inta uurku yahay mid waxtarkeedu yareynayo khatarta GDM ee haweenka ka culus iyo haweenka qaba PCOS. Daraasad ku saabsan Gynecology Endocrinology ayaa muujisay kor u kaca GDM ee dumarka uurka leh ee PCOS oo qaatay kooxdayda myo-inositol waxay ahayd 17.4% oo ka soo horjeeda 54% kooxda kantaroolka.
Ilaha
Hamid A et al. Suxufiga Caafimaadka ee Caddaanka ah. 2015; 5 (3): 93-98.
D-Anna R1, Di Benedetto V, Rizzo P, Raffone E, Interdonato ML, Corrado F, Di Benedetto A. Myo-inositol waxay ka hortagi kartaa sonkorowga uurka ee haweenka PCOS. Gynecol Endocrinol. 2012 Jun; 28 (6): 440-2.
Costantino D, Minozzi G, Minozzi E, Guaraldi C. Saamaynta Metaboliga iyo hormoonnada ee myo-inositol ee haweenka leh cilladda ugxan-sidaha ah ee loo yaqaan 'ovarian syndrome'. Falanqaynta falanqaynta ee Europ 2009; 13 (2): 105-110.
Faafinta V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Myo-inositol halkii D-chiro-inositol ay awood u leedahay inay hagaajiso tayada oocyte ee wareegyada lafdhabarta taranka ee intracytoplasmic. Maxkamad la sii koontaroolayo, la xakameynayo, la kala soocay Falanqaynta falanqaynta ee Europ 2011; 15 (4): 452-457.
Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U. [Cuntada, metformin iyo inositol ee haweenka cayilan iyo cayil leh cudurrada ugxan-yarta ah: saameyn ku yeelashada jir dhiska]. Minerva ginecologica. 2012; 64 (1): 23-29.
[Venturella R, Mocciaro R, Mocciaro R, De Trana E, D'Alessandro P, Morelli M, Zullo F. [Qiimeynta isbeddelka bukaan-socodka, qiyaasta qanjidhada iyo qiyaasta ee bukaan-socodka qaba PCOS syndrome lagu daaweeyo myo-inositol]. Minerva ginecologica. 2012; 64 (3): 239-243.
Genazzani AD, Prati A, Santagni S, iyo al. Jawaabta insulin kala duwan ee daaweynta myo-inositol ee bukaanka cudurrada ugxan-yar ee polycystic syndrome. Gynecol Endocrinol. 2012; 28 (12): 969-973.
Gerli S, Papaleo E, Ferrari A, Di Renzo GC. Iskudhin, laban laab indho-indhayn oo la xakameynayo indho-indheyn: saameynta miyo-inositol ku salaysan hawsha ugxan-la'aanta iyo arrimaha dheef-shiid kiimikaad ee haweenka qaba PCOS. Halkaan ka daawo farmashiyaha. 2007; 11 (5): 347-354.
Raffone E, Rizzo P, Benedetto V. Walxaha xasaasiyadda insulin oo kaliya iyo wada-shaqayn la leh R-FSH oo loogu talagalay in lagu soo saaro haweenka PCOS. Gynecol Endocrinol. 2010; 26 (4): 275-280.
Galazis N, Galazi M, Atiomo W. d-Chiro-inositol iyo muhiimada ay ku leedahay cilladda ugxan-sidaha ah: dib u eegis nidaamsan. Gynecol Endocrinol. 2011; 27 (4): 256-62
Papaleo, E., Faa'iido, V., Baillargeon, JP, et al. (2007). Myo-inositol ee bukaanka qaba cudurka kansarka ugxanta ee loo yaqaan 'polycystic syndrome': Habraac cusub oo loogu talagalay soojiidashada. Endocrinoloji-da dumarka, 23 (12): 700-703.
D 'Anna R, Di Benedetto V, Rizzo P, et al. Myo-inositol waxay ka hortagi kartaa cudurka macaanka ee haweenka PCOS. Gynecol Endocrinol. 2012; 28 (6): 440-442.
Isabella R, Raffone E. Miyuu u baahan yahay ugxansiisku u baahan yahay D-chiro-inositol? J Ovarian Res. 2012 May 15; 5 (1): 14.
Dinicola S1, Chiu TT, Furtay V, Carlomagno G, Bizzarri M. Fikradda ah ee myo-inositol iyo D-chiro-inositol ee daaweynta isku dhafan ee loo yaqaan 'polycystic syndrome. J Clin Pharmacol. 2014 Oct; 54 (10): 1079-92.
Nordio M, Proietti E. Daaweynta isku dhafka ah ee la yiraahdo myo-inositol iyo D-chiro-inositol waxay yaraynaysaa halista cudurada dheef-shiid kiimikaadka ee PCOS marka la barbar dhigo dheecaanka miyooga-inositol oo keliya. Eur Rev Med Pharmacol Sci. 2012 May; 16 (5): 575-81.
Colazingari S, Treglia M, Najjar R, Bevilacqua A. Isku-darka daaweynta myo-inositol oo lagu daray D-chiro-inositol, halkii uu ka noqon lahaa D-chiro-inositol, wuxuu awoodaa inuu hagaajiyo natiijooyinka IVF: natiijooyinka ka soo baxa tijaabo la xaddiday. Arch Gynecol Obstet. 2013 Dec; 288 (6): 1405-11.